Literature DB >> 22504651

Mouse β-defensin 14 (Defb14) promotes tumor growth by inducing angiogenesis in a CCR6-dependent manner.

Johann Röhrl1, Barbara Huber, Gudrun E Koehl, Edward K Geissler, Thomas Hehlgans.   

Abstract

β-Defensins are known for their antimicrobial activity and belong to the molecular barrier of the innate immune system against invading pathogens. In addition, it has been shown that some members of the β-defensin superfamily have the capacity to promote local innate inflammatory and systemic adaptive immune responses, mediated in part by the interaction with CCR6. We found that mouse β-defensin 14 (mBD14, Defb14), a newly identified member of the mouse β-defensin superfamily, is expressed in mouse fibrosarcoma tumor tissue. Tumor cells overexpressing mBD14 demonstrated enhanced solid tumor growth in syngeneic C57BL/6 mice concomitant with increased vascularization of these tumors. Furthermore, mBD14-overexpressing tumors demonstrated increased expression of proangiogenic MIP-2 (CXCL2) ex vivo. In contrast, vascular endothelial growth factor expression was not affected. Cellular analysis of tumor-infiltrating leukocytes revealed a significant increase of CCR6(+) B220(+) lymphocytes in solid tumors derived from mBD14-overexpressing tumor cells. Enhanced tumor growth of mBD14-overexpressing fibrosarcomas was abolished in CCR6-deficient mice, which was paralleled by decreased infiltration of CCR6(+) B220(+) lymphocytes, indicating the requirement of CCR6 expression on host cells. Previously, the interaction of activated, LTαβ(+), lymphocytes with lymphotoxin β-receptor-expressing fibrosarcoma tumor cells has been identified as a new CXCL2-dependent proangiogenic pathway. Coexpression of a soluble lymphotoxin β-receptor:Ig fusion protein, an inhibitor of CXCL2-dependent angiogenesis, in mBD14-overexpressing fibrosarcoma tumor cells abolished enhanced solid tumor growth. Thus, we conclude that mBD14 expression by tumor-infiltrating host cells results in the chemoattraction of CCR6(+) B220(+) lymphocytes, which in turn initiates a proangiogenic pathway leading to enhanced angiogenesis and organized tumor tissue development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504651     DOI: 10.4049/jimmunol.1102442

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Molecular pathways driving disease-specific alterations of intestinal epithelial cells.

Authors:  Rocío López-Posadas; Markus F Neurath; Imke Atreya
Journal:  Cell Mol Life Sci       Date:  2016-09-13       Impact factor: 9.261

2.  Angiogenesis QTL on Mouse Chromosome 8 Colocalizes with Differential β-Defensin Expression.

Authors:  Jason Smith; Fang Liu; Barbara Beyer; Krista Morales; Andrew Reilly; Richard Cole; Bruce J Herron
Journal:  J Biomol Tech       Date:  2015-07

3.  β-Defensins activate human mast cells via Mas-related gene X2.

Authors:  Hariharan Subramanian; Kshitij Gupta; Donguk Lee; Arzu K Bayir; Harry Ahn; Hydar Ali
Journal:  J Immunol       Date:  2013-05-22       Impact factor: 5.422

4.  Immune and Inflammatory Reponses to Staphylococcus aureus Skin Infections.

Authors:  Qi Liu; Momina Mazhar; Lloyd S Miller
Journal:  Curr Dermatol Rep       Date:  2018-09-22

5.  Heterogeneity of Borrelia burgdorferi Sensu Stricto Population and Its Involvement in Borrelia Pathogenicity: Study on Murine Model with Specific Emphasis on the Skin Interface.

Authors:  Aurélie Kern; Gilles Schnell; Quentin Bernard; Amandine Bœuf; Benoît Jaulhac; Elody Collin; Cathy Barthel; Laurence Ehret-Sabatier; Nathalie Boulanger
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 6.  Defensins: A Double-Edged Sword in Host Immunity.

Authors:  Dan Xu; Wuyuan Lu
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

Review 7.  β-Defensins: Farming the Microbiome for Homeostasis and Health.

Authors:  Kieran G Meade; Cliona O'Farrelly
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

Review 8.  Antimicrobial peptides and gut microbiota in homeostasis and pathology.

Authors:  Maureen J Ostaff; Eduard Friedrich Stange; Jan Wehkamp
Journal:  EMBO Mol Med       Date:  2013-08-23       Impact factor: 12.137

9.  Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin.

Authors:  Michal Mlacki; Charbel Darido; Stephen M Jane; Tomasz Wilanowski
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

10.  ΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma.

Authors:  Meggy Suarez-Carmona; Pascale Hubert; Arnaud Gonzalez; Anaelle Duray; Patrick Roncarati; Charlotte Erpicum; Jacques Boniver; Vincent Castronovo; Agnès Noel; Sven Saussez; Olivier Peulen; Philippe Delvenne; Michael Herfs
Journal:  Oncotarget       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.